Impact and clinical management of depression in patients with coronary artery disease

Pharmacotherapy

Volumn 30, Issue 3, 2010, Pages 304-322

  Summers, Kelly M ^a   Martin, Kelly E ^a   Watson, Kristin ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Antidepressants; CAD; Coronary artery disease; Depression; Screening

Indexed keywords

CITALOPRAM; FLUOXETINE; MIRTAZAPINE; NORTRIPTYLINE; PAROXETINE; PLACEBO; SERTRALINE; VENLAFAXINE;

AEROBIC EXERCISE; ANGINA PECTORIS; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; DEPRESSION; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HEART REHABILITATION; HOSPITAL ADMISSION; HUMAN; PATIENT EDUCATION; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; STRESS MANAGEMENT; WEIGHT GAIN;

ANTIDEPRESSIVE AGENTS; BEHAVIOR CONTROL; CORONARY ARTERY DISEASE; DEPRESSION; DEPRESSIVE DISORDER; DRUG INTERACTIONS; DRUG MONITORING; EXERCISE; HUMANS; PSYCHOTHERAPY; QUALITY OF LIFE; RISK-TAKING; TREATMENT OUTCOME;

EID: 77649268290     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.30.3.304     Document Type: Review

References (120)

1. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics-2008 update. Circulation 2008;117:e25-146.
2. Frasure-Smith N, Lesperance F. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry 2008;65:62-71.
3. van Melle JP, de Jonge P, Spijkerman TA, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 2004;66:814-22.
4. Arnold SV, Spertus JA, Ciechanowski PS, et al. Psychosocial modulators of angina response to myocardial ischemia. Circulation 2009;120:126-33.
5. Carney RM, Freedland KE. Treatment-resistant depression and mortality after acute coronary syndrome. Am J Psychiatry 2009;166:410-17.
6. Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, Whooley MA. Depressive symptoms and health-related quality of life: the heart and soul study. JAMA 2003;290:215-21.
7. Whooley MA, de Jonge P, Vittinghoff E, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008;300:2379-88.
8. Rutledge T, Vaccarino V, Johnson BD, et al. Depression and cardiovascular health care costs among women with suspected myocardial ischemia: prospective results from the WISE (women's ischemia syndrome evaluation) study. J Am Coll Cardiol 2009;53:176-83.
9. Frasure-Smith N, Lesperance F, Gravel G, et al. Depression and health-care costs during the first year following myocardial infarction. J Psychosom Res 2000;48:471-8.
10. Rugulies R. Depression as a predictor for coronary heart disease: a review and meta-analysis. Am J Prev Med 2002;23:51-61.
11. Bremmer MA, Hoogendijk WJ, Deeg DJ, Schoevers RA, Schalk BW, Beekman AT. Depression in older age is a risk factor for first ischemic cardiac events. Am J Geriatr Psychiatry 2006;14:523-30.
12. Whang W, Kubzansky LD, Kawachi I, et al. Depression and risk of sudden cardiac death and coronary heart disease in women: results from the nurses' health study. J Am Coll Cardiol 2009;53:950-8.
13. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101-7.
14. Ziegelstein RC, Bush DE, Fauerbach JA. Depression, adherence behavior, and coronary disease outcomes. Arch Intern Med 1998;158:808-9.
15. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998;55:580-92.
16. Ellis JJ, Eagle KA, Kline-Rogers EM, Erickson SR. Depressive symptoms and treatment after acute coronary syndromes. Int J Cardiol 2005;99:443-7.
17. Freeland KE, Lustman PJ, Carney RM, Hong BA. Underdiagnosis of depression in patients with coronary artery disease: the role of nonspecific symptoms. Int J Psychiatry Med 1992;22:221-9.
18. Segal ZV, Whitney DK, Lam RW, for the CANMAT Depression Work Group. Clinical guidelines for the treatment of depressive disorders. III. psychotherapy. Can J Psychiatry 2001;46 (suppl 1):S29-37.
19. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 2000;157:1-45.
20. Mann JJ. The medical management of depression. N Engl J Med 2005;353:1819-34.
21. Strik JJ, Honig A, Lousberg R, et al. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom Med 2000;62:783-9.
22. Lesperance F, Frasure-Smith N, Koszycki D, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian cardiac randomized evaluation of antidepressant and psychotherapy efficacy (CREATE) trial. JAMA 2007;297:367-79.
23. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the enhancing recovery in coronary heart disease patients (ENRICHD) randomized trial. JAMA 2003;289:3106-16.
24. Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute myocardial infarction or unstable angina. JAMA 2002;288: 701-9.
25. Honig A, Kuyper AM, Schene AH, et al. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine. Psychosom Med 2007;69:606-13.
26. van Melle JP, de Jonge P, Honig A, et al. Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry 2007;190:460-6.
27. Lichtman JH, Bigger JT Jr, Blumenthal JA, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment - a science advisory from the American Heart Association prevention committee of the council on cardiovascular nursing, council on clinical cardiology, council on epidemiology and prevention, and interdisciplinary council on quality of care and outcomes research: endorsed by the American Psychiatric Association. Circulation 2008;118:1768-75.
28. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition, text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association, 2000.
29. Swenson JR, O'Connor CM, Barton D, et al. Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. Am J Cardiol 2003;92:1271-6.
30. Glassman AH, Bigger JT, Gaffney M, Shapiro PA, Swenson JR. Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Arch Gen Psychiatry 2006;63:283-8.
31. van den Brink RH, van Melle JP, Honig A, et al. Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: rationale and outline of the myocardial infarction and depression-intervention trial (MIND-IT). Am Heart J 2002;144:219-25.
32. Rajagopalan S, Brook R, Rubenfire M, Pitt E, Young E, Pitt B. Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am J Cardiol 2001;88:196-8.
33. Goldston K, Baillie AJ. Depression and coronary heart disease: a review of the epidemiological evidence, explanatory mechanisms and management approaches. Clin Psychol Rev 2008;28:288-306.
34. Helmeste D, Tang S, Reist C, Vu R. Serotonin uptake inhibitors modulate intracellular calcium mobilization in platelets. Eur J Pharmacol 1995;288:373-7.
35. Miller GE, Freedland KE, Carney RM, Stetler CA, Banks WA. Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun 2003;17:276-85.
36. Stewart JC, Rand KL, Muldoon MF, Kamarck TW. A prospective evaluation of the directionality of the depression-inflammation relationship. Brain Behav Immun 2009;23:936-44.
37. Davidson KW, Schwartz JE, Kirkland SA, et al. Relation of inflammation to depression and incident coronary heart disease (from the Canadian Nova Scotia health survey [NSHS95] prospective population study). Am J Cardiol 2009;103:755-61.
38. Sala M, Lazzaretti M, De Vidovich G, et al. Electrophysiological changes of cardiac function during antidepressant treatment. Ther Adv Cardiovasc Dis 2009;3:29-43.
39. Licht CM, de Geus EJ, Zitman FG, Hoogendijk WJ, van Dyck R, Penninx BW. Association between major depressive disorder and heart rate variability in the Netherlands study of depression and anxiety (NESDA). Arch Gen Psychiatry 2008;65:1358-67.
40. Stein PK, Carney RM, Freedland KE, et al. Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. J Psychosom Res 2000;48:493-500.
41. Bigger JT Jr, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992;85:164-71.
42. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256-62.
43. Gehi A, Haas D, Pipkin S, Whooley MA. Depression and medication adherence in outpatients with coronary heart disease: findings from the heart and soul study. Arch Intern Med 2005;165:2508-13.
44. Carney RM, Blumenthal JA, Stein PK, et al. Depression, heart rate variability, and acute myocardial infarction. Circulation 2001;104:2024-8.
45. Carney RM, Freedland KE, Rich MW, Smith LJ, Jaffe AS. Ventricular tachycardia and psychiatric depression in patients with coronary artery disease. Am J Med 1993;95:23-8.
46. Frasure-Smith N, Lesperance F, Talajic M. The impact of negative emotions on prognosis following myocardial infarction: is it more than depression? Health Psychol 1995;14:388-98.
47. Paraskevaidis I, Parissis JT, Fountoulaki K, Filippatos G, Kremastinos D. Selective serotonin re-uptake inhibitors for the treatment of depression in coronary artery disease and chronic heart failure: evidence for pleiotropic effects. Cardiovasc Hematol Agents Med Chem 2006;4:361-7.
48. Jiang W, Glassman A, Krishnan R, O'Connor CM, Califf RM. Depression and ischemic heart disease: what have we learned so far and what must we do in the future? Am Heart J 2005;150:54-78.
49. Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 2001;104:1894-8.
50. Ziegelstein RC, Meuchel J, Kim TJ, et al. Selective serotonin reuptake inhibitor use by patients with acute coronary syndromes. Am J Med 2007;120:525-30.
51. Serebruany VL, Glassman AH, Malinin AI, et al. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the sertraline antidepressant heart attack randomized trial (SADHART) platelet substudy. Circulation 2003;108:939-44.
52. Pollack MH, Rosenbaum JF, Cassem NH. Propranolol and depression revisited: three cases and a review. J Nerv Ment Dis 1985;173:118-19.
53. Musselman DL, Marzec UM, Manatunga A, et al. Platelet reactivity in depressed patients treated with paroxetine: preliminary findings. Arch Gen Psychiatry 2000;57:875-82.
54. Roose SP, Laghrissi-Thode F, Kennedy JS, et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 1998;279:287-91.
55. Glassman AH, Bigger JT, Gaffney M, Van Zyl LT. Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement. Arch Gen Psychiatry 2007;64:1025-31.
56. Lesperance F, Frasure-Smith N, Laliberte MA, et al. An open-label study of nefazodone treatment of major depression in patients with congestive heart failure. Can J Psychiatry 2003;48:695-701.
57. Yeragani VK, Pesce V, Jayaraman A, Roose S. Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on long-term heart rate variability measures. Biol Psychiatry 2002;52:418-29.
58. Rieckmann N, Gerin W, Kronish IM, et al. Course of depressive symptoms and medication adherence after acute coronary syndromes: an electronic medication monitoring study. J Am Coll Cardiol 2006;48:2218-22.
59. Taylor CB, Youngblood ME, Catellier D, et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 2005;62:792-8.
60. de Jonge P, Honig A, van Melle JP, et al. Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. Am J Psychiatry 2007;164:1371-8.
61. Koertge J, Janszky I, Sundin O, et al. Effects of a stress management program on vital exhaustion and depression in women with coronary heart disease: a randomized controlled intervention study. J Intern Med 2008;263:281-93.
62. Black JL, Allison TG, Williams DE, Rummans TA, Gau GT. Effect of intervention for psychological distress on rehospitalization rates in cardiac rehabilitation patients. Psychosomatics 1998;39:134-43.
63. Sebregts EH, Falger PR, Appels A, Kester AD, Bar FW. Psychological effects of a short behavior modification program in patients with acute myocardial infarction or coronary artery bypass grafting: a randomized controlled trial. J Psychosom Res 2005;58:417-24.
64. Scholz U, Knoll N, Sniehotta FF, Schwarzer R. Physical activity and depressive symptoms in cardiac rehabilitation: long-term effects of a self-management intervention. Soc Sci Med 2006;62:3109-20.
65. Appels A, van Elderen T, Bar F, et al. Effects of a behavioural intervention on quality of life and related variables in angioplasty patients: results of the exhaustion intervention trial. J Psychosom Res 2006;61:1-10.
66. Vizza J, Neatrour DM, Felton PM, Ellsworth DL. Improvement in psychosocial functioning during an intensive cardiovascular lifestyle modification program. J Cardiopulm Rehabil Prev 2007;27:376-85.
67. Stern MJ, Gorman PA, Kaslow L. The group counseling vs exercise therapy study: a controlled intervention with subjects following myocardial infarction. Arch Intern Med 1983;143:1719-25.
68. Taylor CB, Houston-Miller N, Ahn DK, Haskell W, DeBusk RF. The effects of exercise training programs on psychosocial improvement in uncomplicated postmyocardial infarction patients. J Psychosom Res 1986;30:581-7.
69. Frasure-Smith N, Lesperance F, Prince RH, et al. Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction. Lancet 1997;350:473-9.
70. Cossette S, Frasure-Smith N, Lesperance F. Clinical implications of a reduction in psychological distress on cardiac prognosis in patients participating in a psychosocial intervention program. Psychosom Med 2001;63:257-66.
71. Milani RV, Lavie CJ. Impact of cardiac rehabilitation on depression and its associated mortality. Am J Med 2007;120:799-806.
72. Milani RV, Lavie CJ. Prevalence and effects of cardiac rehabilitation on depression in the elderly with coronary heart disease. Am J Cardiol 1998;81:1233-6.
73. Salminen M, Isoaho R, Vahlberg T, Ojanlatva A, Kivela SL. Effects of a health advocacy, counselling, and activation programme on depressive symptoms in older coronary heart disease patients. Int J Geriatr Psychiatry 2005;20:552-8.
74. Schrader G, Cheok F, Hordacre AL, Marker J, Wade V. Effect of psychiatry liaison with general practitioners on depression severity in recently hospitalised cardiac patients: a randomised controlled trial. Med J Aust 2005;182:272-6.
75. Wade V, Cheok F, Schrader G, Hordacre AL, Marker J. Depression after cardiac hospitalization - the identifying depression as a comorbid condition (IDACC) study. Aust Fam Physician 2005;34:985-9.
76. Freedland KE, Skala JA, Carney RM, et al. Treatment of depression after coronary artery bypass surgery: a randomized controlled trial. Arch Gen Psychiatry 2009;66:387-96.
77. Welton NJ, Caldwell DM, Adamopoulos E, Vedhara K. Mixed treatment comparison meta-analysis of complex interventions: psychological interventions in coronary heart disease. Am J Epidemiol 2009;169:1158-65.
78. Rees K, Bennett P, West R, Davey SG, Ebrahim S. Psychological interventions for coronary heart disease. Cochrane Database Syst Rev 2004;(2):CD002902.
79. Lisanby SH. Electroconvulsive therapy for depression. N Engl J Med 2007;357:1939-45.
80. Cristancho MA, Alici Y, Augoustides JG, O'Reardon JP. Uncommon but serious complications associated with electroconvulsive therapy: recognition and management for the clinician. Curr Psychiatry Rep 2008;10:474-80.
81. Fuenmayor AJ, el Fakih Y, Moreno J, Fuenmayor AM. Effects of electroconvulsive therapy on cardiac function in patients without heart disease. Cardiology 1997;88:254-7.
82. Solimene MC. Electroconvulsive therapy and the heart [letter]. Int J Cardiol 2007;114:103.
83. Cheok F, Schrader G, Banham D, Marker J, Hordacre AL. Identification, course, and treatment of depression after admission for a cardiac condition: rationale and patient characteristics for the identifying depression as a comorbid condition (IDACC) project. Am Heart J 2003;146:978-84.
84. Thombs BD, de Jonge P, Coyne JC, et al. Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA 2008;300:2161-71.
85. Post-Myocardial Infarction Depression Clinical Practice Guideline Panel. AAFP guideline for the detection and management of post-myocardial infarction depression. Ann Fam Med 2009;7:71-9.
86. Koszycki D, Lafontaine S, Frasure-Smith N, Swenson R, Lesperance F. An open-label trial of interpersonal psychotherapy in depressed patients with coronary disease. Psychosomatics 2004;45:319-24.
87. Davidson KW, Kupfer DJ, Bigger JT, et al. Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute working group report. Psychosom Med 2006;68:645-50.
88. Hansen BH, Hanash JA, Rasmussen A, Hansen JF, Birket-Smith M. Rationale, design and methodology of a doubleblind, randomized, placebo-controlled study of escitalopram in prevention of depression in acute coronary syndrome (DECARD) [online exclusive article]. Trials 2009;10:20. Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674039/?tool=pubmed.
89. Alvarez W Jr, Pickworth KK. Safety of antidepressant drugs in the patient with cardiac disease: a review of the literature. Pharmacotherapy 2003;23:754-71.
90. Giardina EG, Johnson LL, Vita J, Bigger JT Jr, Brem RF. Effect of imipramine and nortriptyline on left ventricular function and blood pressure in patients treated for arrhythmias. Am Heart J 1985;109:992-8.
91. Raskind M, Veith R, Barnes R, Gumbrecht G. Cardiovascular and antidepressant effects of imipramine in the treatment of secondary depression in patients with ischemic heart disease. Am J Psychiatry 1982;139:1114-17.
92. Varriale P. Fluoxetine (Prozac) as a cause of QT prolongation [case report]. Arch Intern Med 2001;161:612.
93. Wilting I, Smals OM, Holwerda NJ, Meyboom RH, de Bruin ML, Egberts TC. QTc prolongation and torsades de pointes in an elderly woman taking fluoxetine [letter]. Am J Psychiatry 2006;163:325.
94. Goodnick PJ, Jerry J, Parra F. Psychotropic drugs and the ECG: focus on the QTc interval. Expert Opin Pharmacother 2002;3:479-98.
95. Tarabar AF, Hoffman RS, Nelson L. Citalopram overdose: late presentation of torsades de pointes (TdP) with cardiac arrest. J Med Toxicol 2008;4:101-5.
96. Schering Plough. Remeron (mirtazapine ) package insert. Kenilworth, NJ; 2009.
97. Rigotti NA, Thorndike AN, Regan S, et al. Bupropion for smokers hospitalized with acute cardiovascular disease. Am J Med 2006;119:1080-7.
98. Himmelhoch JM, Schechtman K, Auchenbach R. The role of trazodone in the treatment of depressed cardiac patients. Psychopathology 1984;17(suppl 2):51-63.
99. Johnson EM, Whyte E, Mulsant BH, et al. Cardiovascular changes associated with venlafaxine in the treatment of late-life depression. Am J Geriatr Psychiatry 2006;14:796-802.
100. Oslin DW, Ten Have TR, Streim JE, et al. Probing the safety of medications in the frail elderly: evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents. J Clin Psychiatry 2003;64:875-82.
101. Linfante AH, Allan R, Smith SC Jr, Mosca L. Psychosocial factors predict coronary heart disease, but what predicts psychosocial risk in women. J Am Med Womens Assoc 2003;58:248-53.
102. Naqvi TZ, Rafique AM, Andreas V, Rahban M, Mirocha J, Naqvi SS. Predictors of depressive symptoms post-acute coronary syndrome. Gend Med 2007;4:339-51.
103. van Melle JP, de Jonge P, Kuyper AM, et al. Prediction of depressive disorder following myocardial infarction data from the myocardial infarction and depression-intervention trial (MIND-IT). Int J Cardiol 2006;109:88-94.
104. Powell LH, Catellier D, Freedland KE, et al. Depression and heart failure in patients with a new myocardial infarction. Am Heart J 2005;149:851-5.
105. Lesperance F, Frasure-Smith N. Depression in patients with cardiac disease: a practical review. J Psychosom Res 2000;48:379-91.
106. Williams JW Jr, Noel PH, Cordes JA, Ramirez G, Pignone M. Is this patient clinically depressed? JAMA 2002;287:1160-70.
107. Ackermann RT, Rosenman MB, Downs SM, et al. Telephonic case-finding of major depression in a Medicaid chronic disease management program for diabetes and heart failure. Gen Hosp Psychiatry 2005;27:338-43.
108. Whooley MA. Depression and cardiovascular disease: healing the broken-hearted. JAMA 2006;295:2874-81.
109. Thombs BD, Ziegelstein RC, Whooley MA. Optimizing detection of major depression among patients with coronary artery disease using the patient health questionnaire: data from the heart and soul study. J Gen Intern Med 2008;23: 2014-17.
110. Strik JJ, Honig A, Lousberg R, Denollet J. Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction. Psychosomatics 2001;42:423-8.
111. Hilton TM, Parker G, McDonald S, et al. A validation study of two brief measures of depression in the cardiac population: the DMI-10 and DMI-18. Psychosomatics 2006;47:129-35.
112. Wise FM, Harris DW, Carter LM. Validation of the cardiac depression scale in a cardiac rehabilitation population. J Psychosom Res 2006;60:177-83.
113. McManus D, Pipkin SS, Whooley MA. Screening for depression in patients with coronary heart disease (data from the heart and soul study). Am J Cardiol 2005;96:1076-81.
114. Stafford L, Berk M, Jackson HJ. Validity of the hospital anxiety and depression scale and patient health questionnaire-9 to screen for depression in patients with coronary artery disease. Gen Hosp Psychiatry 2007;29:417-24.
115. King KM, Colella TJ, Faris P, Thompson DR. Using the cardiac depression scale in men recovering from coronary artery bypass surgery. J Clin Nurs 2009;18:1617-24.
116. Hare DL, Davis CR. Cardiac depression scale: validation of a new depression scale for cardiac patients. J Psychosom Res 1996;40:379-86.
117. Birks Y, Roebuck A, Thompson DR. A validation study of the cardiac depression scale (CDS) in a UK population. Br J Health Psychol 2004;9:15-24.
118. Schrader G, Cheok F, Hordacre AL, Marker J. Predictors of depression 12 months after cardiac hospitalization: the identifying depression as a comorbid condition study. Aust N Z J Psychiatry 2006;40:1025-30.
119. U.S. National Institutes of Health. ClinicalTrials.gov. Available from http://www.clinicaltrials.gov/. Accessed November 24, 2008.
120. Rollman BL, Belnap BH, LeMenager MS, Mazumdar S, Schulberg HC, Reynolds CF III. The bypassing the blues treatment protocol: stepped collaborative care for treating post-CABG depression. Psychosom Med 2009;71:217-30.